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A B S T R A C T
Vaccinium cylindraceaeum (Azores blueberry) and V. padifolium (Madeira blueberry) are two Portuguese endemic
species, which phytochemical composition and beneficial properties lack scientific validation. In this work, their
potential in vitro inhibitory effects against key enzymes linked to type 2 diabetes and obesity and glycation of
proteins were evaluated. Anthocyanins were predominant in fruits, while hydroxycinnamic acids (in particular
5-O-caffeoylquinic acid) and flavonoids were the main compounds in leaves. Vaccinium extracts showed ef-
fective inhibitions of glucosidases and glycation of proteins and mild activity towards α-amylase and pancreatic
lipase (by comparison with reference compounds). Phenolic composition was strongly correlated with reported
bioactivities. In fact, 5-O-caffeoylquinic can be considered one of the main hypoglycemic and anti-glycation
agents of analysed extracts. Consumption of both Vaccinium species should be encouraged since berries could
offer a dietary option in the prevention and control of diabetes and obesity, while leaves are good candidates for
development of nutraceuticals.
1. Introduction
Type II diabetes (T2D) is a major health concern worldwide (Sancho
& Pastore, 2012; Wang, Camp, & Ehlenfeldt, 2012), characterized by
chronic high blood glucose levels (hyperglycaemia). Inhibition of car-
bohydrate hydrolyzing enzymes is considered one of the effective
measures for regulating T2D by reducing glucose availability in the
digestion tract (Podsędek, Majewska, Redzynia, Sosnowska, &
Koziołkiewicz, 2014; Wang et al., 2012). Currently, this is achieved by
the use of approved oral antidiabetic agents (acarbose, miglitol and
voglibose) for the management of hyperglycaemia (Boath, Grussu,
Stewart, & McDougall, 2012; Sancho & Pastore, 2012). However, these
drugs can cause side/adverse effects such as abdominal pain, flatulence,
diarrhea and liver toxicity (Salehi, Asghari, Esmaeili, Dehghan, &
Ghazi, 2013). As a result, the use of natural products as complementary
strategies to existing medications for the management of T2D is
growing worldwide (Nickavar & Amin, 2011; Podsędek et al., 2014).
Many studies (Boath, Grussu, et al., 2012; Kang, Racicot, Pilkenton,
Kwon, & Apostolidis, 2015; McDougall, Kulkarni, & Stewart, 2008;
Nickavar & Amin, 2011; Podsędek et al., 2014; Wang et al., 2012) re-
ported on the impact of berries polyphenols in the management of T2D
and obesity, through inhibition of digestive enzymes. Additionally, the
intrinsic antioxidant activity of phenolic compounds can prevent the
formation of advanced glycation end products (AGEs), responsible for
many diabetes complications (cardiovascular disease, retinopathy,
cataract development, atherosclerosis, neuropathy, and nephropathy)
(Beaulieu et al., 2010; Ferrier et al., 2012; Harris et al., 2014; Liu et al.,
2011; Wang, Yagiz, Buran, Nunes, & Gu, 2011). Therefore, polyphenols
can offer a complementary dietary approach in prevention and control
of diabetic complications.
The Macaronesia region (Azores and Madeira archipelagos, Canary
and Cape Verde Islands and a coastal strip of Northwest Africa) (Fig. 1)
is home to several endemic berry-producing species, with local/do-
mestic use, but knowledge about their health properties is scarce.
Vaccinium cylindraceum Sm. and V. padifolium Sm. (family Ericaceae),
endemic to Azores and Madeira archipelagos (Portugal), respectively,
are commonly known as uveira or uva-da-serra (blueberries) (Cabrita &
Andersen, 1999; Lima, Baptista, & Albuquerque, 2009). These wild
plants grow as semi-evergreen shrubs or small trees from 3 to 6m tall.
Leaves are oblong to elliptic, usually reddish when new. In the late
summer, they grow ovoid-shape berries of blue-black color, when ripe,
that are consumed fresh and/or used to make jams and liquors (Lima
et al., 2009; Press & Short, 1994). V. cylindraceum is relatively common
in rural areas (above 300m of altitude) in all the Azores islands (except
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Graciosa) (Lima et al., 2009), while V. padifolium is present only at high
altitudes (> 1300m) of Madeira Island (Press & Short, 1994). Their
occurrence is restricted to their natural habitats, although the presence
of specimens in Botanical Gardens (but not extensive cultivation), has
been reported. Previous investigations (Cabrita & Andersen, 1999;
Cabrita, Frøystein, & Andersen, 2000; Lima et al., 2009) had focused
only on the berries’ anthocyanins content, and lacked detailed phenolic
characterization of fruit and leaves.
Various Vaccinium species (blueberries, lingonberries, bilberries,
cranberries, etc.) are reputed to possess beneficial effects in the control
of T2D, mainly achieved by in vitro inhibition of key digestive enzymes
and AGEs formation and antioxidant activity (Beaulieu et al., 2010;
Boath, Grussu, et al., 2012; Ferrier et al., 2012; Harris et al., 2014; Kang
et al., 2015; Liu et al., 2011; Sarkar et al., 2017; Shi, Loftus, McAinch, &
Su, 2017; Wu et al., 2017). In this view, the major aim of this study was
to evaluate, for the first time, the anti-diabetic potential of V. cylin-
draceum and V. padifolium through inhibition of digestive enzymes
linked to T2D and obesity (α,β-glucosidases, α-amylase and lipase) and
glycation of bovine serum albumin (BSA) and antioxidant activities
Additionally, the composition of methanolic extracts of berries and
leaves of both species was determined by HPLC-DAD, improving the
knowledge on these species phytochemical profiles. A comparison on
the contents and diversity of phenolic compounds and bioactive effects
between Macaronesia blueberries species was also established. These
new data may contribute to stimulate the use of these plant resources as
dietary sources of phytochemicals as well as phyto-medicines and/or
health food supplements with anti-diabetic functions.
2. Experimental
2.1. Chemicals and reagents
All reagents and standards were of analytical reagent (AR) grade
unless stated otherwise. Folin–Ciocalteu’s phenol reagent (FCR), so-
dium chloride (> 99.0%), potassium chloride (99.5–100.5%), gallic
acid (> 98%) and potassium acetate (> 99.5%) were obtained from
Panreac (Barcelona, Spain). Ellagic acid (≥96%), 6-hydroxy-2578-tet-
ramethylchroman-2-carboxylic acid (Trolox), 2,2′-azinobis-(3-ethyl-
benzthiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl
(DPPH) and methanol (99.9%) were obtained from Fluka (Lisbon,
Portugal). Caffeic acid (≥98%), N-(1-naphthyl)ethylene-diamine di-
hydrochloride (NEDA, ≥98%), phenazine methosulfate (PMS, ≥90%),
sulfanilamide (≥99%), β-nicotinamide adenine dinucleotide reduced
(NADH, ≥94%), potassium persulfate (99%), sodium carbonate
(100%), α-glucosidase from Saccharomyces cerevisiae (type I), intestinal
acetone powder from rat source of α-glucosidase, β-glucosidase fro-
m almonds, α-amylase from porcine pancreas (type VI-B), lipase (type
II; from porcine pancreas), p-nitrophenyl-α-D-glucopyranoside (α-
pNPG), p-nitrophenyl-β-D-glucopyranoside (β-pNPG), p-nitrophenyl bu-
tyrate (pNPB), bovine serum albumin (BSA, ≥98%), D-(−)-ribose
(≥99%), aminoguanidine hydrochloride (AMG, ≥98%), conduritol B
epoxide (≥95%), acarbose, orlistat and formic acid (98%) were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA). 5-O-caffeoylquininc
acid (5-O-CQA,> 95%) and 1-deoxynojirimycin (1-DNJ; 95–99%) were
obtained from Biopurify phytochemicals LTD (Chengdu, China).
Nitroblue tetrazolium chloride (NBT, 90%) was obtained from Acros
Organics, o-phosphoric acid (85%) from BDH AnalaR and (+)-catechin
hydrated (> 99%) from Extrasynthese (Genay, France). Hydrochloric
acid (37%), aluminium chloride (98%) and quercetin dihydrate
(> 99%) from Riedel-de Haen (Hanover, Germany) and acetic acid
Fig. 1. Macaronesia region, composed of Azores (1) and Madeira (2) archipelagos (Portugal), Canary Islands, Cape Verde Islands and a coastal strip of Northwest Africa.
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glacial purchased from Fischer Scientific (Bishop Meadow, UK). Soluble
starch (p.a.), D-(−)-fructose, potassium iodate (99.5%), sodium ni-
troprusside (99%), ethylenediaminetetraacetic acid (EDTA,> 99%)
and sodium azide (> 99%) were obtained from Merck (Darmstadt,
Germany). LC–MS grade acetonitrile (CH3CN, 99%) (LabScan; Dublin,
Ireland) ultrapure water (Milli-Q Waters purification system; 18MΩ cm
at 23 °C; Millipore; Milford, MA, USA) were used for the HPLC-MS
analysis.
2.2. Sample preparation and extraction of phenolic compounds
Samples of V. cylindraceum and V. padifolium were collected in the
wild in different archipelagos of Portugal (Azores and Madeira, re-
spectively), between August and September of 2014 (Table 1). In the
case of V. cylindraceum, plant material was send by air transportation to
Madeira Island, the day after collection, in styrofoam boxes over dry ice
and delivered to Centro de Química da Madeira (CQM), within 3 days
after harvest. V. padifolium was collected, placed in adequate re-
frigerated transporters and freeze-dried in the same day as collection.
Plants were authenticated by specialists of Madeira Botanical Garden,
Herbarium (Madeira, Funchal) where vouchers have been deposited
(Table 1).
For analysis, plant material was separated into leaves and berries
(fully ripe), destemmed, and washed. In the case of V. padifolium, leaves
were divided in two groups: young leaves (red colored tips) and mature
leaves (fully green). This was not verified for V. cylindraceum species.
Samples were lyophilized (Alpha 1–2 LD plus freeze dryer, CHRIST),
ground to powder in a mechanic grinder, and stored at −20 °C. For
phenolic extraction, 1 g of dry material was mixed with 25mL of me-
thanol in an ultra-sonic bath (Bandelin Sonorex, Germany) at 35 kHz
and 200W for 60min (room temperature). For berries, an extraction
solution composed of MeOH/H2O (acidulated with 7% acetic acid)
(80:20, v/v) was used. After sonication, solutions were filtered through
Whatman No.1 filter papers, concentrated to dryness under reduced
pressure in a rotary evaporator (Buchi Rotavapor R-114; USA) at 40 °C.
The extraction procedure was conducted in duplicate for all samples
and the resulting extracts were stored at 4 °C until further analysis.
In the case of leaves, an additional step was used for removal of
chlorophylls. After the first filtration step, a small amount of activated
charcoal was added to the liquid extract and, after mixing for a few
seconds, the solution was filtered. Then, it was concentrated to dryness
and stored as aforementioned.
The total soluble solids (TSS) were determined in fresh pulp from
berries using a digital Atago RX-1000 refractometer. The TSS content
varied between 11.7 and 12.1 °Brix, which are within the range re-
ported previously for other Vaccinium berries (6–15.5 °Brix) (Garzón,
Narváez, Riedl, & Schwartz, 2010; Jaakola, Määttä-Riihinen,
Kärenlampi, & Hohtola, 2004).
2.3. Chromatography and Mass spectrometry conditions
HPLC analysis was performed on a Dionex ultimate 3000 series
instrument (Thermo Scientific Inc., California, USA) equipped with a
binary pump, an autosampler, a column compartment (kept at 30 °C)
and a diode array detector (DAD) coupled with a Bruker Esquire model
6000 ion trap mass spectrometer (Bremen, Germany). The experimental
conditions were the same as previously reported (Spínola, Llorent-
Martínez, Gouveia, & Castilho, 2014), which details were as follows:
Phenomenex Gemini C18 chromatographic column (5 µm,
250× 3.0mm i.d.); mobile phase: A: acidified water (0.1% formic acid,
v/v), B: CH3CN; flow rate: 0.4 mLmin−1; gradient elution 20% B (0 in),
25% B (10–20min), 50% B (40min), 100% B (42–47min), 20% A
(49–55min); injection volume: 5 μL; column temperature: 30 °C.
Mass spectrometry conditions: dry and nebulizer gas (N2): flow
10mLmin−1 and pressure 50 psi; nebulizer temperature and tempera-
ture: 365 °C and +4500 V, respectively; scanning range: m/z 100–1000.
For analysis, dry extracts (DE) were re-dissolved in the initial HPLC
mobile phase (H2O:CH3CN; 80:20), filtered through 0.45 µm PTFE
membrane filters, and injected in the HPLC equipment.
2.4. Quantification of main polyphenols
For this quantitative analysis, one polyphenol was selected as the
standard for each group, and was used to calculate relative individual
concentrations by HPLC-DAD (Spínola et al., 2014). Caffeic and 5-O-
caffeoylquinic acids were used for hydroxycinnamic and caffeoylquinic
acids determination, respectively. Anthocyanins standard was cyanidin
3-O-glucoside. Quercetin, (+)-catechin, hesperidin, apigenin and el-
lagic acid were the standards used for the flavonols, flavanols, flava-
nones, flavones and ellagitannins, respectively. Stock standard solutions
(1000mg L−1) were prepared in methanol and six different con-
centrations (5–100mg L−1) were prepared for the calibration curves,
plotting peak area versus concentration (R2≥ 0.990 in all cases). Total
individual phenolic content (TIPC) was defined as the sum of the re-
lative amounts of compounds in extracts.
2.5. In vitro anti-diabetic assays
2.5.1. Yeast α-glucosidase inhibition assay
This assay was adapted from a previous report (Podsędek et al.,
2014). In a 96-well plate, 50 μL of sample extract (sequential dilutions)
was combined with 50 μL of enzyme solution (0.1 mgmL−1) and 50 μL
of 5mmol L−1 α-pNPG solution. All solutions were prepared in 0.1M
phosphate buffer (pH 6.9). The mixture was incubated at 37 °C for
20min in the dark. Finally, 100 μL of 0.1 M Na2CO3 solution was added
and the absorbance was read at 405 nm (Victor3 microtiter reader,
Perkin-Elmer, Germany). Acarbose and 1-DNJ were used as positive
controls and the IC50 values (mgmL−1 DE) were determined from the
least-squares regression line of the logarithmic concentrations plotted
against percentage inhibition.
2.5.2. Rat α-Glucosidase inhibition assay
For this assay, 0.5 g of intestinal acetone powder from rat was dis-
solved in 10mL of 0.1M phosphate buffer (pH 6.9) and sonicated for
10min. After centrifugation (Sigma 3K30) at 1753g for 10min at 4 °C,
the resulting supernatant was diluted 5 times with above buffer and was
used as the enzyme solution. The measurement of enzyme inhibition
was performed as described above (Section 2.5.1).
2.5.3. β-Glucosidase inhibition assay
The assay for β-glucosidase was carried out as above (Section 2.5.1)
using β-pNPG as substrate. Conduritol B epoxide and 1-DNJ were used
as positive controls.
2.5.4. α-Amylase inhibition assay
The assay was performed as described before (Podsędek et al.,
2014), with slight modifications (Spínola, Llorent-Martínez, Gouveia-
Figueira, & Castilho, 2016): 20 μL of sample extract (serial dilutions)
and 40 μL of 2 g L−1 starch solution were mixed with 20 μL of α-
Table 1
Sample information, collection area, dates and voucher numbers. For a better visualiza-
tion of collection sites, check Fig. 1.
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amylase (0.1 mgmL−1). All solutions were prepared in 0.1 M phosphate
buffer (pH 6.9). After incubation (20min; 37 °C), the reaction was
stopped by the addition of 80 μL of 0.4 M HCl followed by 100 μL of
5mmol L−1 I2 (in 5mmol L−1 KI) and the absorbance was read at
620 nm (Victor3 microtiter reader, Perkin-Elmer). Acarbose was used as
positive control.
2.5.5. Lipase inhibition assay
The method for measuring lipase activity was adapted (Kim et al.,
2010): 40 μL of sample extract (serial dilutions) was mixed with 20 μL
of substrate solution (10mM of p-NPB in ethanol) and 40 μL of the
enzyme (2.5mgmL−1 in 0.1M phosphate buffer, pH 8.0). After in-
cubation (20min; 37 °C) absorbance was read at 405 nm (Victor3 mi-
crotiter reader, Perkin-Elmer). Orlistat was used as positive control.
2.5.6. BSA glycation assay
Formation of AGEs was measured in 96 black well-plates, with
slight modifications from a published protocol (Séro et al., 2013). Each
well contained 50 μL of BSA solution (10mgmL−1), 80 μL of 0.1 M
phosphate buffer (containing sodium azide, 3 mM, pH 7.4), 50 μL of
ribose or fructose solution (0.5M) and 20 μL of sample extracts (serial
dilutions). Plates were incubated for 24 h at 37 °C and were analysed at
an excitation wavelength of 355 nm and emission wavelength of
460 nm (Victor3 microtiter reader, Perkin–Elmer). AMG and quercetin
were used as positive controls and the anti-glycation activities were
expressed as IC50 value (mgmL−1 DE) as described before (Section
2.5.1).
2.6. Total phenolic and flavonoid contents and in vitro antioxidant assays
2.6.1. Total phenolic content (TPC)
TPC determinations followed a previous protocol (Zheng & Wang,
2001), with some modifications (Spínola et al., 2016): 50 μL of sample
extract (5 mgmL−1 in MeoH) were mixed with 1.25mL of FCR (diluted
1:10 with water) and 1mL of 7.5% Na2CO3 solution. After 30min in the
dark at room temperature, the absorbance was measured at 765 nm in a
Perkin Elmer UV–Vis Lambda 2 spectrophotometer (Oberlingen, Ger-
many). The amounts of total phenolics were expressed as mg of gallic
acid equivalents (GAE) g−1 DE, based on the gallic acid calibration
curve.
2.6.2. Total flavonoid content (TFC)
TFC was measured based on previous procedure (Akkol, Göger,
Koşar, & Başer, 2008) with some adjustments (Spínola et al., 2016):
0.5 mL of sample solution (2.5 mgmL−1 in MeOH) was mixed with
1.5 mL of methanol, 2.8 mL of distilled water, 0.1 mL of CH3COOK (1
mol L−1), and 0.1mL of AlCl3·6H2O (10% in MeOH). The absorbance
was measured at 415 nm (UV–Vis Lambda 2, Perkin Elmer) after 30min
of reaction (room temperature, in the dark). The final results were
expressed as mg of rutin equivalent (RUE) g−1 DE, based on the rutin
calibration curve.
2.6.3. ABTS radical scavenging activity
Determination of antioxidant activity was adapted from previous
works (Dudonné, Vitrac, Coutière, Woillez, & Mérillon, 2009): 40 μL of
sample solution (5mgmL−1 in MeOH) was added to 1.96mL of
ABTS%+ solution (diluted in PBS pH 7.4 until the absorbance is
0.700 ± 0.021 at 734 nm). The reduction of absorbance at 734 nm
(UV–Vis Lambda 2, Perkin Elmer) was measured during 6min, and the
results were expressed as μmol of Trolox equivalent (TE) g−1 DE, based
on the Trolox calibration curve.
2.6.4. DPPH radical scavenging activity
The DPPH assay followed a previously reported method (Dudonné
et al., 2009), with slight adjustments (Spínola et al., 2016): 100 μL of
sample solution (5mgmL−1 in MeOH) was added to 3.5mL of DPPH
radical solution (0.06 mmol L−1 in MeOH). Absorbance was measured
at 516 nm (UV–Vis Lambda 2, Perkin Elmer), after 30min of reaction in
the dark (room temperature) and results were expressed as μmol TE g−1
of DE.
2.6.5. Nitric oxide (NO) scavenging activity
Fifty microliters of 20mM sodium nitroprusside was mixed with
50 μL of sample extract (5 mgmL−1) for 60min, at room temperature
(under light) based on a previous work (Sousa, Valentão, Ferreres,
Seabra, & Andrade, 2008). All solutions were prepared in 0.1M phos-
phate buffer (pH 7.4). After incubation, 50 μL of Griess reagent (1%
sulfanilamide and 0.1% NEDA in 2% phosphoric acid) was added. Then,
the absorbance was read at 550 nm (Victor3 microtiter reader; Perki-
n–Elmer) and the results were expressed as μmol TE g−1 DE.
2.6.6. Superoxide radical (SO) scavenging activity
Twenty-five microliters of sample extract (5 mgmL−1) was mixed
with 200 μL 0.1 mmol L−1 EDTA, 62 µmol L−1 NBT and 98 µmol L−1
NADH solution (Ewing & Janero, 1995). The reaction was initiated with
the addition of 25 μL of 33 µmol L−1 PMS (containing 0.1mM EDTA) to
each well. All solutions were prepared in 0.1 M phosphate buffer (pH
7.4). The absorbance was read at 550 nm (Victor3 microtiter reader;
Perkin-Elmer) and the results were expressed as μmol TE g−1 DE.
2.7. Statistical analysis
All samples were assayed in triplicate and results are given as the
means ± standard deviations. Data was analysed using one-way ana-
lysis of variance (ANOVA) followed by Tukey’s post hoc test using SPSS
for Windows, IBM SPSS Statistics 20 (SPSS, Inc., USA). A value of
p < .05 was considered statistically significant. Pearson correlation
coefficients (r) were determined to corroborate relationships between
selected parameters. Principal Component Analysis (PCA) was applied
to the concentrations of polyphenols determined in different morpho-
logical parts of Vaccinium species.
3. Results and discussion
Identification of phytochemicals in analysed Vaccinium species was
achieved based on spectrum data, authentic standards (when available)
and literature (Tables S1 and S2 – Supplementary Material).
In case of V. cylindraceum, 81 phytochemicals were tentatively
identified, with 75 in berries and 80 in leaves extracts (Tables S1 and S2
– Supplementary Material): 64 polyphenols and 17 non-phenolic com-
pounds (oligosaccharides, organic acids, terpenoids, coumarins). An-
thocyanins, ellagic acid and tricin derivatives were only detected in
berries.
Similar phenolic profiles were found in berries and leaves of V.
padifolium. In total, 100 phytochemicals were identified, with 76 in
berries and 78 in leaves (young and mature) extracts (Tables S1 and S2
– Supplementary Material): 91 polyphenols and 9 other compounds
(oligosaccharides and organic acids). In this case, anthocyanins were
detected berries and young leaves, while ellagitannins were present
only in berries.
3.1. Quantification of polyphenols
In the present study, the amounts of 66 polyphenols were de-
termined via HPLC-DAD using the corresponding relative standards
(Table 2). Only the main compounds were quantified, since the low
amounts of other minor components did not allow an accurate quan-
tification.
Quantitative results indicated that anthocyanins were the most
abundant compounds in berries (78–81% of TIPC); other relevant fa-
milies were hydroxycinnamic acids (HCAs) (9–13%), ellagic acid deri-
vatives (2.39–5.50%), flavonols (3.20–3.81%) and flavanols
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Table 2
Quantification of main polyphenolic compounds present in berries and leaves of targeted Vaccinium species (mg g−1 DE).
No. Assigned identification Berries Leaves
VC VP VC VP-YL VP-ML
Anthocyanins
3 Delphinidin-O-(pentosyl)hexoside 0.82 ± 0.03a 1.88 ± 0.02b
5 Delphinidin-O-hexoside 7.88 ± 0.03a 13.77 ± 0.20b
10 Cyanidin-O-glucoside 6.65 ± 0.20
17 Delphinidin-O-hexoside 26.81 ± 0.96a 29.40 ± 0.22b
22 Petunidin-O-hexoside 15.25 ± 0.11b 10.02 ± 0.40a
25 Cyanidin-O-pentoside 3.58 ± 0.16
31 Delphinidin-O-rhamnoside 2.14 ± 0.09
35 Malvidin-O-hexoside 1.36 ± 0.03
38 Peonidin-O-hexoside 2.04 ± 0.04a 3.62 ± 0.11b
49 Malvidin-O-hexoside 10.57 ± 0.07b 9.49 ± 0.28a
53 Malvidin-O-pentoside 2.13 ± 0.09b 1.08 ± 0.04a
64 Malvidin-O-rhamnoside 0.63 ± 0.01b 0.13 ± 0.01a
Total 68.27 ± 1.15b 70.73 ± 1.01c 10.23 ± 0.32a
Hydroxycinnamic acids
10 Caffeoylisocitrate 0.35 ± 0.01
18 Caffeoylquinic acid derivative 0.33 ± 0.01b 0.29 ± 0.01a
34 3-O-Caffeoylquinic acid dimer 0.65 ± 0.02b 0.22 ± 0.01a
55 Caffeoylquinic acid derivative 0.39 ± 0.01a 0.38 ± 0.01a
57 Caffeoylquinic acid derivative 0.48 ± 0.01a 0.27 ± 0.01b
58 Caffeic acid-O-hexoside 0.56 ± 0.04c 0.40 ± 0.02a 0.49 ± 0.02b 0.60 ± 0.02d 0.70 ± 0.02e
68 5-O-Caffeoylquinic acid 5.57 ± 0.05a 8.88 ± 0.10b 33.11 ± 1.30c 66.05 ± 0.52d 87.27 ± 1.11e
78 Caffeoylquinic acid 0.15 ± 0.02a 0.22 ± 0.03b 1.03 ± 0.04c 2.64 ± 0.05e 2.00 ± 0.01d
80 Caffeoylshikimic acid 0.26 ± 0.01
87 5-p-Coumaroylquinic acid 0.28 ± 0.003a 0.55 ± 0.01b 1.62 ± 0.04c 1.58 ± 0.02c
93 Caffeoylquinic acid derivative 0.33 ± 0.01b 0.24 ± 0.04a
95 5-p-Coumaroylquinic acid 0.78 ± 0.02
100 Caffeoylquinic acid derivative 0.77 ± 0.02b 0.25 ± 0.01a
104 Methyl-5-O-caffeoylquinic acid 0.27 ± 0.04c 0.24 ± 0.01bc 0.19 ± 0.02a 0.78 ± 0.02d 0.96 ± 0.02e
106 Coumaroyl iridoid 0.31 ± 0.01a 0.34 ± 0.01a 0.49 ± 0.01b 1.06 ± 0.02d 0.75 ± 0.01c
107 Coumaric acid derivative 0.86 ± 0.01a 1.62 ± 0.02b
111 Coumaroyl iridoid 0.52 ± 0.02a 0.55 ± 0.01a
126 Coumaric acid derivative 0.11 ± 0.01
129 4-Benzoyl-9-p-coumaroyl-DOA 0.23 ± 0.01a 1.05 ± 0.02b 1.44 ± 0.03c
135 Coumaric acid derivative 0.93 ± 0.02a 13.02 ± 0.24b 13.48 ± 0.06c
142 Coumaric acid derivative 0.13 ± 0.01a 1.18 ± 0.05b 1.40 ± 0.01c
159 Coumaric acid derivative 0.04 ± 0.01a 0.08 ± 0.01b
Total 7.99 ± 0.11a 11.64 ± 0.14b 38.10 ± 1.15c 91.85 ± 0.86d 112.91 ± 1.08e
Hydroxybenzoic acids
40 Protocatechuic acid-O-hexoside 0.80 ± 0.02b 0.60 ± 0.01a
56 Protocatechuic acid derivative 1.15 ± 0.02
Total 0.80 ± 0.02a 1.74 ± 0.03b
Flavonols
102 Myricetin-O-hexoside 0.19 ± 0.03a 0.29 ± 0.01b
109 Rutin 0.71 ± 0.04a 0.81 ± 0.06b
115 Cinchonain Ib 0.24 ± 0.01
117 Quercetin-O-hexoside 4.93 ± 0.11a 17.98 ± 0.63c 10.68 ± 0.01b
118 Myricetin-O-deoxyhexoside 0.41 ± 0.01a 0.58 ± 0.01b
119 Quercetin-O-hexoside 0.23 ± 0.01a 0.88 ± 0.02b 9.06 ± 0.30e 7.26 ± 0.20d 6.51 ± 0.16c
125 Quercetin-O-pentoside 0.65 ± 0.02a 0.63 ± 0.02a
128 Cinchonain-Ib 1.38 ± 0.03
131 Cinchonain-Ib 1.24 ± 0.05c 0.54 ± 0.02b 0.46 ± 0.01a
133 Quercetin-O-(acetyl)hexoside 0.15 ± 0.01
134 Kaempferol-O-hexoside 11.65 ± 0.24
139 6-Hydroxy-7,4-dimethoxy-quercetin-O-hexoside 0.14 ± 0.01
140 Isorhamentin-O-hexoside 0.14 ± 0.01
144 Quercetin-O-(acetyl)hexoside 0.11 ± 0.01a 0.16 ± 0.02b
148 Kaempferol-O-(acetyl)hexoside 2.96 ± 0.05b 2.57 ± 0.02a
153 Cinchonain-Ib 4.40 ± 0.04c 0.65 ± 0.01b 0.60 ± 0.02a
156 6-Hydroxy-7,4-dimethoxy-quercetin-O-(acetyl)hexoside 0.20 ± 0.01
158 Kaempferol-O-(acetyl)hexoside 0.21 ± 0.01a 0.26 ± 0.01b 0.46 ± 0.02c
160 6-Hydroxy-7,4-dimethoxy-quercetin derivative 0.39 ± 0.01b 0.38 ± 0.01b 0.34 ± 0.01a
Total 3.21 ± 0.04b 2.90 ± 0.05a 34.75 ± 0.74e 31.39 ± 0.78d 23.14 ± 0.27c
Flavanols
50 Procyanidin dimer (B type) 3.28 ± 0.08
60 Procyanidin dimer (B type) 1.92 ± 0.03
75 Procyanidin dimer (B type) 1.22 ± 0.03a 11.31 ± 0.38b
79 Catechin 0.83 ± 0.04a 8.14 ± 0.21d 2.89 ± 0.07c 1.66 ± 0.06b
(continued on next page)
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(0.50–3.11%). Delphinidin-O-hexoside (17) was main compound in
berries (31.80–32.42%), followed by petunidin-O-hexoside (22)
(18.09%) and malvidin-O-hexoside (49) (12.54%) in V. cylindraceum; a
different delphinidin-O-hexoside (5) (15.18%), petunidin-O-hexoside
(22) (11.05%) and malvidin-O-hexoside (49) (10.46%) were quantified
in V. padifolium. In leaves, HCAs were dominant (36.85–87.05%), fol-
lowed by flavonols (17.84–33.62%) and flavanols (2.80–27.79%).
Anthocyanins (7.61%) were only present in V. padifolium (young
leaves), while flavanones and hydroxybenzoic acids were quantifiable
in V. cylindraceum (0.99% and 1.68%, respectively). Leaves were rich
sources of 5-O-caffeoylquinic acid (5-O-CQA) (68) (37.98–67.73%)
(Table 2). Kaempferol-O-hexoside (134) (11.27%), B-type procyanidin
dimer (75) (10.94%), quercetin-O-hexoside (119) (8.76%) and catechin
(79) (7.81%) were also relevant in V. cylindraceum; quercetin-O-hexo-
side (117) (8.23–13.38%), coumaric acid derivative (135)
(9.69–10.39%) and quercetin-O-hexoside (119) (5.02–5.40%) in V.
padifolium. Cyanidin-3-glucoside (C3G) content was also significant in
V. padifolium young leaves (4.95%).
Inter-species variations were found in this study, which are due to
genetic factors (species/cultivar) and to edaphoclimatic conditions
(soil, sun exposure, rainfall, etc.) of different growing locations (Sarkar
et al., 2017; Shi et al., 2017). In general, V. padifolium extracts showed
richer phenolic contents than V. cylindraceum (p < .05). Exceptions
were observed in flavonols and flavanols contents. In the latter group,
amounts were 6 to 8-times higher than in V. padifolium (Table 2). HCAs
content was superior in V. padifolium, mostly due to the higher 5-O-CQA
amounts (almost 3 times-fold higher).
Previously (Cabrita & Andersen, 1999; Cabrita et al., 2000; Lima
et al., 2009), malvidin-3-O-glucoside, delphinidin-3-O-galactoside and
petunidin-3-O-glucoside were described, as main anthocyanins of ana-
lysed Vaccinium species. This was not the case in the present study,
which could be due to differences in sample preparation methodologies
and collection year. By contrast, cyanidin glycosides were the main
polyphenols found in V. vitis-idea and V. meridionale Swartz berries
(Beaulieu et al., 2010; Garzón et al., 2010). Quercetin and kaempferol
glycosides are reported as the most abundant flavonoids in Vaccinium
berries (Chen, Xin, Yuan, Su, & Liu, 2014; Jaakola et al., 2004;
Martineau et al., 2006; Vrhovsek, Masuero, Palmieri, & Mattivi, 2012),
which agrees with obtained data (Table 2). Comparable flavonols va-
lues were reported in V. myrtillus leaves (Jaakola et al., 2004; Martineau
et al., 2006).
Higher content of phenolic compounds in the leaves were also noted
for other Vaccinium species (Bujor, Le Bourvellec, Volf, Popa, & Dufour,
2016; Jaakola et al., 2004; Oszmiański, Wojdyło, Lachowicz,
Gorzelany, & Matłok, 2016; Teleszko & Wojdyło, 2015). 5-O-CQA was
also main compound in V. myrtillus and V. angustifolium leaves (Bujor
et al., 2016; Martineau et al., 2006), with relative higher contents in the
latter species (104mg g−1 DE). Similarly to V. padifolium, coumaroyl
derivatives were very common in V. macrocarpon leaves (Oszmiański
et al., 2016). Another interesting issue is the content of anthocyanins in
V. padifolium (young leaves), which was less diverse (only cyanidin
glycosides) and in considerably lower concentrations (p < .05) than in
fruits. The designation of “young leaves” refers to those recently de-
veloped on the extremities of twigs. Cyanidin glycosides were also re-
ported in V. myrtillus (Jaakola et al., 2004) and V. macrocarpon
(Oszmiański et al., 2016) leaves, although, higher concentrations were
found in the latter species (22.38–28.26mg g−1 DE). The presence of
anthocyanins in V. padifolium (young leaves) could be attributed to the
higher sun exposure, which activates polyphenols production (Jaakola
et al., 2004). C3G and quercetin glycosides are known to play si-
multaneously a predominant role in defense against high solar radiation
in Vaccinium leaves (Jaakola et al., 2004). Intra-species differences
(p < .05) were also observed in V. padifolium leaves. Anthocyanins
were present only in young leaves not in mature ones). Both HCAs and
anthocyanins can act as antioxidants/radiation protectors. It seems that
the biosynthesis of anthocyanins is faster and happens first to protect
leaves from radiation (Jaakola et al., 2004). HCAs take longer to be
produced and when sufficient amounts are reached, anthocyanin pro-
duction stops.
TIPC of analysed Vaccinium species varied from 84.13 to
134.42mg g−1 DE (Table 2). Previously (Teleszko & Wojdyło, 2015),
lower TIPC were documented for berries and leaves extracts of V.
macrocarpon and V. myrtillus (16.24–18.83 and
68.84–110.95mg g−1 DE, respectively). By contrast, superior amounts
were determined in V. macrocarpon extracts (91.11–137.44 and
215.50–388.94mg g−1 DE for berries and leaves, respectively)
(Oszmiański et al., 2016). TIPC of analysed leaves were within the
range reported for V. angustifolium and V. myrtillus (Bujor et al., 2016;
Martineau et al., 2006) (97.4–185.18mg g−1 DE), while berries had
lower total phenolic and anthocyanins contents (4.59–41.1 and
22.3–34.5 mg g−1 DE, respectively).
TPC and TFC, measured by colorimetric assays (Table 2), showed
Table 2 (continued)
No. Assigned identification Berries Leaves
VC VP VC VP-YL VP-ML
84 Procyanidin trimer (B type) 0.57 ± 0.02a 4.08 ± 0.04c 1.99 ± 0.06b 1.99 ± 0.03b
124 Procyanidin dimer (A type) 0.45 ± 0.01
Total 2.62 ± 0.07b 0.45 ± 0.01a 28.73 ± 0.61e 4.88 ± 0.105d 3.65 ± 0.07c
Flavanones
145 Phlorizin 1.02 ± 0.04
Total 1.02 ± 0.04
Ellagic acid derivatives
24 Ellagic acid derivative 2.012 ± 0.09
26 Tergallagic acid 1.15 ± 0.06
39 Methyl-ellagic acid derivative 2.85 ± 0.13
47 Methyl-ellagic acid-O-pentoside 0.86 ± 0.01b 0.10 ± 0.01a
Total 2.01 ± 0.06a 4.96 ± 0.18b
TIPC 84.13 ± 1.44a 90.68 ± 1.74b 103.37 ± 2.55c 134.42 ± 2.06d 129.70 ± 1.41d
TPC1 76.63 ± 1.30a 88.58 ± 4.01b 186.98 ± 2.64c 341.25 ± 2.27e 297.70 ± 9.07d
TFC2 11.49 ± 0.08a 14.67 ± 0.19b 35.41 ± 0.20c 127.91 ± 2.16e 94.09 ± 0.64d
1 Determined by the Folin-Ciocalteu method (mg GAE g−1 DE).
2 Determined by the aluminium chloride method (mg RUE g−1 DE). VC: V. cylindraceum; VP: V. padifolium; YL: young leaves; ML: mature leaves); DOA: 2,7-anhydro-3-deoxy-2-
octulopyranosonic acid. Means in the same line not sharing the same letter are significantly different at p < .05 probability level.
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the same power trend between morphological parts and species
(p < .05). TPC was within the range reported in literature for other
Vaccinium berries (12.4–630mg GAE g−1 DE) but lower TFC
(114.21mg RUE g−1 DE) were documented (Bujor et al., 2016; Ferrier
et al., 2012; Harris et al., 2014; Salehi et al., 2013; Venskutonis et al.,
2016; Wang et al., 2011).
3.2. In vitro digestive enzyme inhibition assays
Consumption of blueberries and its by-products has been suggested
to have potential health benefits in ameliorating the development of
T2D (Shi et al., 2017). In the present work, the inhibitory capacity of
berries and leaves extracts of both Vaccinium species under study, was
investigated on digestive enzymes responsible for the carbohydrates
and lipids metabolism (α-,β-glucosidases, α-amylase and lipase)
(Table 3).
From different morphological parts, extracts showed different in-
hibitory activities against targeted enzymes. For the yeast α-glucosi-
dases assay, leaves showed the best activities (p < .05). Higher in-
hibitory activities were observed for the leaves of V. padifolium (namely
young leaves). All samples showed stronger inhibitory efficacy
(p < .05) than commercial drug acarbose (Table 3). The same trend
was previously observed for other Vaccinium berries (Salehi et al.,
2013; Wu et al., 2017). Young leaves of V. padifolium showed com-
parable activities to 1-DNJ, a known glucosidases inhibitor extracted
from mulberry leaves (Morus spp. L.). Remarkable differences were
observed between results of yeast and rat glucosidase assays. In the
latter case, higher IC50 values were determined (Table 3). A correlation
of 0.840 at p < .05 was obtained from results of both models. Ad-
ditionally, acarbose and 1-DNJ were more effective towards mamma-
lian enzyme (about 17 and 65 times higher, respectively) and displayed
the higher inhibitory activities among tested samples. The discrepancy
of results could be attributed to structural differences in the catalytic
site of enzymes (Shai, Magano, Lebelo, & Mogale, 2011). Data obtained
from the mammalian enzyme seem to be closer to the human digestion
system, thus, it is a preferable model to search for new hypoglycemic
agents.
For the β-glucosidase assay, berries extracts were less effective than
the standards conduritol B epoxide (a known β-glucosidase inhibitor)
and 1-DNJ (p < .05).
Our experiments have shown a mild inhibition towards α-amylase
activity (Table 3), since all samples presented higher IC50 values than
acarbose (p < .05). Leaves extracts were the most active (except for V.
padifolium mature leaves). In this case, higher inhibitory activities were
observed for leaves of V. cylindraceum. Berries of V. arctostaphylos
showed comparable IC50 values (1.91 mgmL−1) towards α-amylase
(Nickavar & Amin, 2010) while leaves were more effective
(0.53 mgmL−1) (Nickavar & Amin, 2011) than analysed extracts
(Table 3).
Leaves were more active than berries (p < .05) against lipase, al-
beit showing lower activities than commercial drug orlistat
(0.47 mgmL−1). Similarly, other Vaccinium berries have been docu-
mented as active digestive enzymes inhibitors (Boath, Grussu, et al.,
2012; McDougall et al., 2008; Podsędek et al., 2014; Wang et al., 2012).
High correlations between TIPC and inhibition of glucosidases and
lipase (r≥−0.937) were observed. Similar results were stated in lit-
erature (Flores, Singh, Kerr, Pegg, & Kong, 2013; Salehi et al., 2013;
Wang et al., 2012). However, lack of correlation was obtained for α-
amylase (r≥−0.498). These data are consistent with that of previous
works (Flores et al., 2013; Podsędek et al., 2014), suggesting that the
type of polyphenols is more important for the inhibitory effects than
total phenolic amounts (Kang, Racicot, Pilkenton, & Apostolidis, 2016;
Podsędek et al., 2014). Moreover, synergistic and/or antagonistic ef-
fects can occur between phytochemicals present in crude extracts
(Boath, Grussu, et al., 2012). In the present work, HCAs and antho-
cyanins seem to be the main glucosidases inhibitors (r≥−0.818)
Flavonols and flavan-3-ols were key contributors for α-amylase in-
hibition (r≥−0.860), while HCAs and flavanols (r≥−865) were
important for lipase inhibition.
Previous studies have shown that α-glucosidase is susceptible to
inhibition by a range of berries polyphenols, in particular cyanidin
glycosides and caffeoylquinic acids (CQAs) (Boath, Grussu, et al., 2012;
Kang et al., 2015; Shi et al., 2017). In fact, the high contents of 5-O-CQA
may explain the more potent inhibitory activity of blueberries than
other berry species (McDougall et al., 2008). Considering that 5-O-CQA
was the most abundant in leaves of targeted Vaccinium species, its in-
hibitory potential was further analysed and it was found to be a pow-
erful inhibitor of targeted enzymes (Table 3), with lower IC50 values
than positive controls in yeast a-glucosidase, β-glucosidase and lipase
assays (p < .05). In case of rat α-glucosidase, its effectiveness was only
inferior to 1-DNJ and acarbose. For α-amylase, its potency was com-
parable to berries extracts (Table 3). It seems that 5-O-CQA is a more
effective inhibitor of glucosidases than of other digestive enzymes. In
fact, extracts with the highest contents in 5-O-CQA were the most active
(V. padifolium > V. cylindraceum). Previously (Boath, Stewart, &
McDougall, 2012; Spínola & Castilho, 2017; Worsztynowicz, Napierała,
Białas, Grajek, & Olkowicz, 2014), 5-O-CQA has been reported as a
strong inhibitor of digestive enzymes. Inhibition of α-glucosidase by
Table 3
In vitro inhibitory activities (IC50, mgmL−1) of Vaccinium extracts towards digestive enzymes and glycation of BSA.
α-Glucosidase β-Glucosidase α-Amylase Lipase BSA Glycation
Yeast Rat Ribose Fructose
Berries
VC 1.10 ± 0.04e 4.36 ± 0.14 g 9.88 ± 0.40f 2.78 ± 0.04f 6.50 ± 0.34e 2.35 ± 0.15e 1.53 ± 0.11d
VP 1.03 ± 0.03e 4.13 ± 0.16 g 9.36 ± 0.09f 2.63 ± 0.09f 5.97 ± 0.38e 2.09 ± 0.14e 1.35 ± 0.06d
Leaves
VC 0.85 ± 0.03d 1.64 ± 0.06f 4.59 ± 0.40d 1.05 ± 0.03b 4.20 ± 0.27d 1.21 ± 0.02d 0.60 ± 0.01c
VP-YL 0.58 ± 0.01b 0.82 ± 0.04d 2.33 ± 0.19c 1.75 ± 0.06d 2.18 ± 0.09c 0.75 ± 0.04b 0.41 ± 0.01b
VP-ML 0.76 ± 0.02c 0.86 ± 0.02e 2.60 ± 0.09c 2.03 ± 0.04e 3.56 ± 0.31d 0.88 ± 0.03c 0.49 ± 0.01b
5-O-CQA 0.36 ± 0.02a 0.27 ± 0.02c 0.39 ± 0.01a 1.20 ± 0.04c 0.31 ± 0.01a 0.14 ± 0.01a 0.20 ± 0.01a
Acarbose 2.06 ± 0.04f 0.12 ± 0.01b – 0.02 ± 0.001a – – –
1-DNJ 0.65 ± 0.02b 0.01 ± 0.01a 0.45 ± 0.02b – – – –
Conduritol B epoxide – – 8.94 ± 0.19e – – – –
Orlistat – – – – 0.47 ± 0.02b – –
Aminoguanidine – – – – – 9.56 ± 0.36e 2.29 ± 0.13e
Quercetin – – – – – 0.11 ± 0.01a 0.24 ± 0.02a
VP: Vaccinium padifolium; VC: Vaccinium cylindraceum; YL: Young Leaves; ML: Mature Leaves. Means in the same column not sharing the same letter are significantly different at p < .05
probability level.
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this molecule appears to be non-competitive, suggesting binding to, or
interaction with, other sites than the recognized active site of the en-
zyme (McDougall et al., 2008). The present data (Table 3) demonstrate
that 5-O-CQA can be considered as one of the main active hypoglycemic
agents present leaves extracts. Nevertheless, the action of flavonoids
cannot be ruled out and may also contribute for the obtained results.
Tannins (ellagitannins and proanthocyanidins) are active α-amylase
and lipase inhibitors, but not effective against α-glucosidase (Boath,
Grussu, et al., 2012; Kang et al., 2015; McDougall et al., 2008). How-
ever, their effectiveness may be potentiated by anthocyanins (Podsędek
et al., 2014). For example, quercetin and malvidin-3-O-glucoside, iso-
lated from leaves and berries of V. arctostaphylos, have been reported as
active α-amylase components (Nickavar & Amin, 2010; Nickavar &
Amin, 2011). Therefore, it seems that different berry components could
interact to additively or synergistically inhibit amylase and glucosidases
(McDougall et al., 2008). The higher effect of V. cylindraceum on α-
amylase is indicative of its high flavanol content (Table 3). In fact, if we
remove young leaves from V. padifolium we obtain a higher correlation
(r=−0.72).
Previously (Boath, Grussu, et al., 2012; Sancho & Pastore, 2012), a
synergistic effect between acarbose, cyanidin glycosides and proan-
thocyanidins from berry extracts was observed. Therefore, this combi-
nation may lead to a reduction of the dose of acarbose in the man-
agement of hyperglycaemia, consequently reducing side effects of
acarbose consumption (flatulence and diarrhea). In addition, identi-
fying extracts with high α-glucosidase but mild α-amylase inhibitory
potential is recommended to prevent fermentation of undigested starch
in colon (Boath, Grussu, et al., 2012).
3.3. In vitro anti-glycation assays
Inhibition of AGEs formation, which is induced by hyperglycaemia,
represents another potential therapeutic approach for some diabetic
complications (nephropathy, retinopathy, among others) (Beaulieu
et al., 2010; Chinchansure, Korwar, Kulkarni, & Joshi, 2015; Harris
et al., 2014). Tested extracts showed potent in vitro inhibitory potential
to glycation of BSA (IC50≤ 2.35mgmL−1 DE for both models)
(Table 3). Leaves showed the highest anti-glycation activities (V. padi-
folium > V. cylindraceum) (p < .05). Higher glycation rates were
found in BSA-ribose assay (p < .05). It is known that glycation ability
occurs in the following increasing order: D-glucose < D-fructose < D-
ribose. This is explained by the almost planar structure of the aldofur-
anose ring of ribose which causes its instability and high rate of
anomerization; the unstable ring is thus susceptible to reactions with
nucleophiles, such as amino groups, giving rise to its high efficiency in
protein glycation (Sompong, Meeprom, Cheng, & Adisakwattana,
2013).
All samples were more effective than AMG (an experimental anti-
diabetic drug) in both models (p < .05), in agreement with previous
data (Liu et al., 2011). However, an opposite trend was found in an-
other study (Wang et al., 2011). Quercetin standard proved to be the
best inhibitor (p < .05). Other authors found similar results (Beaulieu
et al., 2010; Harris et al., 2014). The analysed extracts potency was
inferior to those reported for other Vaccinium species (Beaulieu et al.,
2010; Ferrier et al., 2012; Harris et al., 2014; Liu et al., 2011). These
discrepancies can arise from different analytical methodologies (type
and concentration of sugar, time of reaction, etc.) or sample composi-
tion. Nevertheless, these data demonstrate other beneficial effects of
targeted extracts in the control of diabetes, besides lowering hy-
perglycemia.
A strong correlation was observed for inhibition of AGEs formation
and TIPC (r≥−0.906), HCAs and flavonols as main contributors
(r≥−0.860). Cyanidin-3-glycosides and quercetin-glycosides were the
main active antiglycation agents in V. vitis-idaea berry extract (Beaulieu
et al., 2010), while proanthocyanidins appeared to be the potent in-
hibitors from V. macrocarpon (Liu et al., 2011). Although anthocyanins
are effective AGEs inhibitors, it seems that anthocyanin-procyanidin
mixture or total phenolic composition is more pertinent to anti-glyca-
tion activity (Harris et al., 2014; Wang et al., 2011). 5-O-CQA, main
compound in leaves extracts, is known as a potent inhibitor of AGEs
formation (Chinchansure et al., 2015; Spínola & Castilho, 2017). The
obtained results (Table 3) are corroborative to this fact: 5-O-CQA has a
better superior IC50 value to AMG and comparable to quercetin
(p < .05). In fact, V. padifolium leaves showed the strongest inhibitions
compared with other berry species studied by our group (Myrica faya
and Rubus grandifolius) with lower CQAs content (unpublished data).
Polyphenols are thought to act by several mechanisms of action in the
prevention of AGEs formation (Chinchansure et al., 2015), and in the
case of 5-O-CQA its potential effect results probably from its antioxidant
activity or chelating of transitional metal ions (Gugliucci, Bastos,
Schulze, & Souza, 2009). Therefore, 5-O-CQA can be considered as one
of the main anti-glycation agents on analysed Vaccinium species.
3.4. In vitro antioxidant assays
The increased free-radical production (like NO and O2−) by oxi-
dative stress is associated with the initiation and progression of diabetes
and related complications (Sancho & Pastore, 2012; Wang et al., 2012).
Therefore, exogenous scavengers can be useful in the prevention and/or
reduction of oxidative stress involved in this metabolic disorder (Sarkar
et al., 2017). For that reason, the antioxidant effects of targeted Vac-
cinium extracts towards and synthetic (ABTS%+ and DPPH) and bio-
logical (NO and O2−) radicals were measured (Fig. 2).
The antioxidant activities of Vaccinium spp. extracts varied between
0.27 and 7.91mmol TE g−1 DE (Fig. 2). Leaves were the most active
samples (p < .05), regardless of the assay, which is in agreement with
the higher phenolic composition (Table 2). A similar trend was ob-
served previously (Bujor et al., 2016; Oszmiański et al., 2016; Teleszko
& Wojdyło, 2015). V. padifolium extracts (berries and leaves) showed
the strongest antioxidant activities (p < .05). According to literature
(Sarkar et al., 2017; Shi et al., 2017; Venskutonis et al., 2016), differ-
ences in blueberries species/cultivars antioxidant activities are mainly
related to genetic factors, edaphoclimatic and cultivation conditions.
Other Vaccinium species have shown high antioxidant activities (Bujor
et al., 2016; Chen et al., 2014; Garzón et al., 2010; Podsędek et al.,
2014; Wang et al., 2012; Wu et al., 2017). By comparison, V. myrtillus
and V. macrocarpon extracts presented lower scavenging activity to-
wards ABTS and DPPH radicals (0.14–0.40mmol TE g−1 DE) (Bujor
et al., 2016; Teleszko & Wojdyło, 2015) than analysed species (Fig. 2).
On another study, V. macrocarpon presented higher antioxidant effects
on ABTS%+ assay (2.29 and 9.81mmol TE g−1 DE) (Oszmiański et al.,
2016). A simultaneous scavenging activity of targeted species towards
NO and O2− was demonstrated (Fig. 2), which might also prevent the
formation of other more reactive species like peroxynitrite and hy-
droxyl radical (Sousa et al., 2008). Sambucus lanceolata extracts, ana-
lysed under the same conditions (Pinto et al., 2017), presented lower
antioxidant activities (0.02–2.87mmol TE g−1 DE) than analysed Vac-
cinium species. This may be related to the inferior TIPC of both berries
and leaves (≤27.22mg g−1 DE).
In the present study, relevant correlations between TIPC, TPC and
TFC and measured antioxidant activities were observed (r≥ 0.890).
Thus, polyphenols are significant contributors to measured activities:
HCAs (r≥ 0.865) > anthocyanins (r≥ 0.774) > flavonoids
(r≥ 0.648). Other works also noticed strong correlation between
polyphenols and antioxidant activity of berry producing plants (Bujor
et al., 2016; Chen et al., 2014; Podsędek et al., 2014; Sarkar et al., 2017;
Teleszko & Wojdyło, 2015; Wang et al., 2012). Anthocyanins and 5-O-
CQA seem the major contributors to the in vitro antioxidant properties
of blueberries (Oszmiański et al., 2016; Shi et al., 2017; Venskutonis
et al., 2016; Wang et al., 2012; Wu et al., 2017).
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3.5. Principal Component Analysis (PCA)
PCA statistical tool was applied to concentrations of 66 compounds
(Table 2), in order to establish a relationship between morphological
parts and Vaccinium species. PC1, that explained 86% of the total
variability (Fig. 3A), shows Vaccinium samples discrimination based on
morphological parts, where the berries are below PC1 axis and leaves
are projected in PC1 positive. On the other hand, PC2 (that explained
12% of the total variability) separated leaves based on species: V. cy-
lindraceaum are above PC2 axis, while V. padifolium is positioned in PC2
negative (Fig. 3A). Taking into account the loading plot (Fig. 3B), the
compounds that most contribute to these results were 5-O-caffeoyl-
quinic acid (68), B-type procyanidin dimer (75) and kaempferol-O-
hexoside (134). From this data, we can infer that Vaccinium berries
have alike phenolic compositions, while previous compounds can be
used as potential discriminatory geographical/taxonomical markers for
leaves of Vaccinium species endemic to Azores and Madeira archipe-
lagos.
4. Conclusions
This study reports the first full phytochemical analysis ever con-
ducted on V. cylindraceum and V. padifolium, leading to the identifica-
tion of 160 phenolic compounds. Quantitative analysis showed that
anthocyanins were the main compounds of berries and HCAS in leaves,
with special emphasis to 5-O-CQA. Berries from different species re-
vealed a similar composition; variations were more significant for
leaves (HCAs and flavanols contents). High inhibitory activities were
observed for glucosidases and glycation of BSA, but extracts showed a
mild inhibition for α-amylase and lipase. Specifically, 5-O-CQA can be
considered to contribute most for the potential bioactivities of leaves.
The phenolic content was also highly correlated to the antioxidant ac-
tivity of analysed extracts.
Both Vaccinium species proved to be suitable for application in the
management and control of hyperglycaemia and obesity, but the most
promising results were obtained for V. padifolium (in particular young
leaves). Genotype× environment interactions are most critical factors
which determine in vitro anti-diabetic effects of blueberry extracts
(Sarkar et al., 2017). Fruits are the main commercial products of berry
plants and there has been an increased interest and consumption in
recent years of these wild blueberry species. Considering their compo-
sition and potential health benefits, this study provided scientific data
to reinforce their agricultural and commercial exploitation with some
future economic impact in the local economy. Additionally, the ob-
tained results may assist in developing high added value functional
ingredients for food supplements, nutraceuticals and/or functional
foods from berries leaves, which are a comparatively cheap plant source
considered essentially as wastes or by-products resulting from pruning.
From a parallel study, targeted species have been submitted to in
vitro gastrointestinal digestion simulation to evaluate the stability/





















































Fig. 2. Antioxidant activities of Vaccinium extracts
measured by different in vitro assays. Data represent
the mean ± standard deviation (n=3). VC: V. cy-
lindraceum; VP: V. padifolium; B: berries; L: leaves; YL:



































Fig. 3. (A) PC1×PC2 of scores scatter plot between Vaccinium species morphological
parts and collection areas; (B) PC1×PC2 of loading plot of the main source of variability
between Vaccinium species morphological parts and collection areas (Azores blueberry:
V. cylindraceaum; Madeira blueberry: V. padifolium).
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beneficial properties (results to be published elsewhere). Additional
toxicity and clinical studies are a follow-up investigation to determine
the “real” impact of these berry species on T2D and obesity therapy.
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